{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T13:53:50Z","timestamp":1769176430772,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hemodynamic instability related to renal replacement therapy (HIRRT) is a serious complication of continuous renal replacement therapy (CRRT) in critically ill patients with acute kidney injury (AKI), significantly increasing mortality risk. The pathophysiology involves complex interactions between cardiac output and systemic vascular resistance. Therefore, identifying early and reliable predictive parameters for HIRRT is clinically crucial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This prospective, observational cohort study was conducted in an Internal Medicine Intensive Care Unit between July 2023 and October 2024. Thirty-six patients undergoing CRRT with invasive monitoring via the PiCCO\n                      <jats:sup>\u00ae<\/jats:sup>\n                      device were enrolled. Hemodynamic parameters were recorded. HIRRT was defined exclusively as a decrease in systolic blood pressure\u2009\u2265\u200920 mmHg or a decrease in mean arterial pressure\u2009\u2265\u200910 mmHg. Changes in vasopressor or inotropic therapy were not included in the diagnostic criteria for HIRRT. To avoid classifying transient or clinically insignificant fluctuations as HIRRT, the decrease in blood pressure had to be present in at least two consecutive measurements (approximately 10\u201315\u00a0min). This definition is consistent with prior CRRT studies that use objective blood pressure thresholds. Statistical analyses included the Mann-Whitney U test, chi-square test, logistic regression, and receiver operating characteristic (ROC) curve analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age of the patients was 68.1\u2009\u00b1\u200918.3 years, and 69.4% were male. The most common indication for CRRT was uremic complications (52.8%), and the most frequent comorbidity was hypertension (55.6%). A total of 83.3% of patients were on vasopressor support, and 38.9% were on mechanical ventilation. HIRRT occurred in 55.5% of patients during CRRT, and in 60% of these patients, it developed within the first hour. The HIRRT group had a significantly lower cardiac index (CI) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002) and a higher systemic vascular resistance index (SVRI) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003). Additionally, the HIRRT group had higher baseline mean arterial pressure (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.015) and baseline diastolic blood pressure (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003), and a significantly greater total ultrafiltration volume (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018). Multivariate analysis identified a low CI (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018) and a high mean arterial pressure (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.031) as independent predictors. ROC analysis revealed that the optimal cut-off value for the mean arterial pressure was 78 mmHg (AUC: 0.759, 95% CI: 0.597\u20130.922) and that for the CI was 2.61\u00a0L\/min\/m\u00b2 (AUC: 0.794, 95% CI: 0.642\u20130.946).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Low baseline cardiac index and elevated mean arterial pressure emerged as independent predictors of HIRRT, whereas higher SVRI was significant only in univariate analysis, indicating an association but not independent predictive value. Collectively, these findings suggest that a reduced capacity to increase cardiac output in response to hemodynamic stress, together with alterations in vascular tone regulation, may play a central role in the development of HIRRT. While these parameters may facilitate early identification of high-risk patients and support individualized management strategies, further validation in larger, multicenter cohorts is required.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-025-04712-0","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T16:46:29Z","timestamp":1766249189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The value of transpulmonary thermodilution parameters in predicting hemodynamic instability in intensive care patients undergoing continuous renal replacement therapy"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7254-7809","authenticated-orcid":false,"given":"Cagla Sena","family":"Keser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6355-835X","authenticated-orcid":false,"given":"Mete","family":"Erdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-111X","authenticated-orcid":false,"given":"Mahmut","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6406-9221","authenticated-orcid":false,"given":"Gurhan","family":"Taskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3704-3763","authenticated-orcid":false,"given":"Levent","family":"Yamanel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"4712_CR1","unstructured":"Prescription of CRRT: a pathway to optimize therapy - PMC [Internet]. [cited 2024 Jun 19]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7060300\/."},{"key":"4712_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/IJNRD.S245621","volume":"16","author":"SM Hamrahian","year":"2023","unstructured":"Hamrahian SM, Vilayet S, Herberth J, F\u00fcl\u00f6p T. Prevention of intradialytic hypotension in hemodialysis patients: current challenges and future prospects. Int J Nephrol Renovascular Disease. 2023;16:173.","journal-title":"Int J Nephrol Renovascular Disease"},{"issue":"10","key":"4712_CR3","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00134-019-05707-w","volume":"45","author":"A Douvris","year":"2019","unstructured":"Douvris A, Zeid K, Hiremath S, Bagshaw SM, Wald R, Beaubien-Souligny W, et al. Mechanisms for hemodynamic instability related to renal replacement therapy: a narrative review. Intensive Care Med. 2019;45(10):1333.","journal-title":"Intensive Care Med"},{"issue":"6","key":"4712_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/sdi.12626","volume":"30","author":"MM Assimon","year":"2017","unstructured":"Assimon MM, Flythe JE. Intradialytic hypotension definitions of intradialytic hypotension. Semin Dial. 2017;30(6):464\u201372.","journal-title":"Semin Dial"},{"issue":"8","key":"4712_CR5","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1093\/ndt\/gfq763","volume":"26","author":"B Caplin","year":"2011","unstructured":"Caplin B, Kumar S, Davenport A. Patients\u2019 perspective of haemodialysis-associated symptoms. Nephrol Dial Transpl. 2011;26(8):2656\u201363.","journal-title":"Nephrol Dial Transpl"},{"key":"4712_CR6","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1038\/sj.ki.5001975","volume":"70","author":"W Sulowicz","year":"2006","unstructured":"Sulowicz W, Radziszewski A. Pathogenesis and treatment of dialysis hypotension. Kidney Int. 2006;70:S36\u20139.","journal-title":"Kidney Int"},{"issue":"12","key":"4712_CR7","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1093\/ndt\/gfg450","volume":"18","author":"A Tisler","year":"2003","unstructured":"Tisler A, Akocsi K, Borbas B, Fazakas L, Ferenczi S, Gorogh S, et al. The effect of frequent or occasional dialysis-associated hypotension on survival of patients on maintenance haemodialysis. Nephrol Dialysis Transplantation. 2003;18(12):2601\u20135.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"3","key":"4712_CR8","first-page":"223","volume":"29","author":"A Messina","year":"2023","unstructured":"Messina A, Alicino V, Cecconi M. Transpulmonary thermodilution. Curr Opin Crit Care. 2023;29(3):223.","journal-title":"Curr Opin Crit Care"},{"key":"4712_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13054-017-1739-5","volume":"21","author":"X Monnet","year":"2017","unstructured":"Monnet X, Teboul JL. Transpulmonary thermodilution: advantages and limits. Crit Care. 2017;21:147.","journal-title":"Crit Care"},{"issue":"4","key":"4712_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000380903","volume":"39","author":"A Akhoundi","year":"2015","unstructured":"Akhoundi A, Singh B, Vela M, Chaudhary S, Monaghan M, Wilson GA, et al. Incidence of adverse events during continuous renal replacement therapy. Blood Purif. 2015;39(4):333\u20139.","journal-title":"Blood Purif"},{"issue":"9","key":"4712_CR11","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00134-007-0754-4","volume":"33","author":"S Uchino","year":"2007","unstructured":"Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med. 2007;33(9):1563\u201370.","journal-title":"Intensive Care Med"},{"key":"4712_CR12","unstructured":"NKF KDOQI guidelines [Internet]. [cited 2024 Nov 2]. Available from: https:\/\/kidneyfoundation.cachefly.net\/professionals\/KDOQI\/guidelines_cvd\/intradialytic.htm."},{"key":"4712_CR13","doi-asserted-by":"crossref","unstructured":"Pathil A, Stremmel W, Schwenger V, Eisenbach C. The influence of haemodialysis on haemodynamic measurements using transpulmonary thermodilution in patients with septic shock: an observational study. Eur J Anaesthesiol. 2012;30.","DOI":"10.1097\/EJA.0b013e328358543a"},{"issue":"1","key":"4712_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13613-021-00883-9","volume":"11","author":"G Chazot","year":"2021","unstructured":"Chazot G, Bitker L, Mezidi M, Chebib N, Chabert P, Chauvelot L, et al. Prevalence and risk factors of hemodynamic instability associated with preload-dependence during continuous renal replacement therapy in a prospective observational cohort of critically ill patients. Ann Intensive Care. 2021;11(1):95.","journal-title":"Ann Intensive Care"},{"key":"4712_CR15","unstructured":"https:\/\/kdigo.org\/wp-content\/uploads\/2023\/10\/KDIGO-AKI-Guideline_Scope-of-Work_25Oct2023_Final.pdf [Internet]. [cited 2024 Jun 20]. Available from: https:\/\/kdigo.org\/wp-content\/uploads\/2023\/10\/KDIGO-AKI-Guideline_Scope-of-Work_25Oct2023_Final.pdf."},{"issue":"2","key":"4712_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1053\/j.ajkd.2003.10.021","volume":"43","author":"JT Kielstein","year":"2004","unstructured":"Kielstein JT, Kretschmer U, Ernst T, Hafer C, Bahr MJ, Haller H, et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis. 2004;43(2):342\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4712_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semnephrol.2018.10.003","volume":"39","author":"L Di Lullo","year":"2019","unstructured":"Di Lullo L, Reeves PB, Bellasi A, Ronco C. Cardiorenal syndrome in acute kidney injury. Semin Nephrol. 2019;39(1):31\u201340.","journal-title":"Semin Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04712-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04712-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04712-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T13:06:41Z","timestamp":1769173601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04712-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4712"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04712-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This prospective study was conducted in accordance with the principles of the Declaration of Helsinki and adhered to relevant institutional and national ethical guidelines. Ethical approval was granted by the Ethics Committee of G\u00fclhane Training and Research Hospital (Approval No.: 27.09.2023-2023\/203). Written informed consent was obtained from all participants prior to their inclusion in the study, or from their legally authorized representatives in cases where patients were intubated. To ensure confidentiality and compliance with data protection regulations, all patient data were anonymized and handled in strict accordance with privacy standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}